Replies to post #207028 on $Pistol Pete$, $Mick$ & Friends Stock Picks /news,

[mick]

thank you, CYDY
RE;

Shareholders meeting tomorrow. CEO said they are going to discuss details of signed non-binding agreement apparently for significant milestone payments with some BP. Tomorrow could be very interesting.


Date: Thursday, September 12, 2019
Time: 9:30 a.m. PT / 12:30 p.m. ET
Dial In: For audio: 877-407-2986 or 201-378-4916
The live audio webcast may also be accessed via CytoDyn’s corporate website at

HTTP://www.cytodyn.com

under the Investors section/IR Calendar and will be archived for two weeks.

Web participants are encouraged to go to the website 15 minutes
prior to the start of the meeting to register,

download and install any necessary software.

The webcast can also be accessed via the following link:

https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/32197/indexl.html

=========================================================
CytoDyn Inc. (OTC: CYDY) Nader Pourhassan, Ph.D, CEO.

CEO Dr. Nader Pourhassan updates investors on the latest developments for CytoDyn’s lead drug candidate, Leronlimab (PRO 140) for use as a Combination Therapy to treat HIV, and expecting FDA approval in early 2020.
Dr. Pourhassan also shares what’s ahead for the company’s pipeline for cancer indications

[trding]

$CYDY: US HIV only deal closes in 6 weeks, 90M milestone + 50% net royalties, all sales and launch costs on partner. More licensing deals to come in cancer, gvhd, nash, and HIV outside US with people I in data room right now saying they will give an offer.

Starts at 20:23